temozolomide has been researched along with gadolinium dtpa in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chenevert, TL; Kessler, ML; Lawrence, TS; Shen, Z; Tatro, DS; Ten Haken, R; Tsien, CI | 1 |
| Artemov, D; Kato, Y; Okollie, B | 1 |
| Beijnen, JH; Boogerd, W; Buckle, T; Heerschap, A; Kemper, EM; Küsters, B; Leenders, W; Lyons, S; van Tellingen, O | 1 |
| Artemov, D; Holm, DA; Kato, Y; Okollie, B | 1 |
| Coenen, HH; Eble, MJ; Galldiks, N; Herzog, H; Holy, R; Kaiser, HJ; Langen, KJ; Pinkawa, M; Piroth, MD; Stoffels, G | 1 |
| Golomb, G; Grad, E; Guez, D; Last, D; Levi-Kalisman, Y; Mardor, Y; Meirow, H; Nordling-David, MM; Salomon, S; Sharabi, S; Yaffe, R | 1 |
| Mardaleishvili, K; Orkodashvili, G | 1 |
7 other study(ies) available for temozolomide and gadolinium dtpa
| Article | Year |
|---|---|
Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain Neoplasms; Carboxymethylcellulose Sodium; Combined Modality Therapy; Contrast Media; Dacarbazine; Dose Fractionation, Radiation; Female; Gadolinium DTPA; Glioma; Humans; Interferon Inducers; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Poly I-C; Polylysine; Radiotherapy Dosage; Radiotherapy, Conformal; Survival Analysis; Temozolomide; Treatment Outcome | 2005 |
Noninvasive 1H/13C magnetic resonance spectroscopic imaging of the intratumoral distribution of temozolomide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carbon Isotopes; Contrast Media; Dacarbazine; Feasibility Studies; Female; Gadolinium DTPA; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Mice; Mice, SCID; Phantoms, Imaging; Temozolomide | 2006 |
Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies.
Topics: Animals; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain Neoplasms; Cell Division; Cell Line, Tumor; Contrast Media; Dacarbazine; Drug Screening Assays, Antitumor; Female; Gadolinium DTPA; Immunohistochemistry; Luciferases; Luminescence; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Temozolomide | 2006 |
Noninvasive detection of temozolomide in brain tumor xenografts by magnetic resonance spectroscopy.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Carbon Radioisotopes; Cell Line, Tumor; Dacarbazine; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Temozolomide; Tissue Distribution; Xenograft Model Antitumor Assays | 2010 |
Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dose Fractionation, Radiation; Female; Fluorine Radioisotopes; Gadolinium DTPA; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Tumor Burden; Tyrosine | 2011 |
Liposomal temozolomide drug delivery using convection enhanced delivery.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Convection; Dacarbazine; Drug Delivery Systems; Gadolinium DTPA; Glioblastoma; Liposomes; Male; Nanoparticles; Particle Size; Polyethylene Glycols; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Survival Rate; Temozolomide; Tumor Burden | 2017 |
USE OF PERFUSION MRI FOR DETERMINATION OF IRRADIATION VOLUMES IN RADIOTHERAPY OF PATIENTS WITH BRAIN GLIOMA.
Topics: Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Radiation; Gadolinium DTPA; Glioma; Humans; Neoplasm Grading; Neoplasm Recurrence, Local; Radiometry; Temozolomide; Treatment Outcome | 2018 |